Finance

Iran rejects U.S. talks for now as wait for Hormuz deal drags on

Sara Gharaibeh, Patrick Sykes, Bloomberg

Replimune in the spotlight: Earnings loom days after FDA approval

https://www.investing.com/news/earnings/replimune-in-the-spotlight-earnings-loom-days-after-fda-approval-93CH-4847740 Investing.com

Iran rejects U.S. talks for now as wait for Hormuz deal drags on

Sara Gharaibeh, Patrick Sykes, Bloomberg

Sana Biotechnology faces earnings test as CAR-T program advances

https://www.investing.com/news/earnings/sana-biotechnology-faces-earnings-test-as-cart-program-advances-93CH-4847741 Investing.com

Biohaven earnings set to show cash burn ahead of epilepsy data

https://www.investing.com/news/earnings/biohaven-earnings-set-to-show-cash-burn-ahead-of-epilepsy-data-93CH-4847742 Investing.com

Hub Group earnings ahead: Can execution match freight rebound?

https://www.investing.com/news/earnings/hub-group-earnings-ahead-can-execution-match-freight-rebound-93CH-4847743 Investing.com

Latest articles

spot_imgspot_img